(Reuters) -India is in talks to buy 50 million doses of Pfizer Inc and German partner BioNTech SE's COVID-19 vaccine, the Wall Street Journal reported https://www.wsj.com/articles/india-looks-to-western-covid-19-vaccines-to-ease-supply-shortage-11628674884?mod=latest_headlines on Wednesday, citing people familiar with the matter.
Pfizer and the Indian health ministry did not immediately respond to Reuters request for comments. The drugmaker has not yet sought permission for use of its vaccine in India.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!